摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(benzylsulfonyl)piperidin-4-one | 267666-08-0

中文名称
——
中文别名
——
英文名称
1-(benzylsulfonyl)piperidin-4-one
英文别名
1-benzylsulfonylpiperidin-4-one
1-(benzylsulfonyl)piperidin-4-one化学式
CAS
267666-08-0
化学式
C12H15NO3S
mdl
MFCD09941085
分子量
253.322
InChiKey
FEYBMJAHQOAMBC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.416
  • 拓扑面积:
    62.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Probing acid replacements of thiophene PTP1B inhibitors
    摘要:
    The following account describes our systematic effort to replace one of the carboxylate groups of our diacid thiophene PTP1B inhibitors. Active hits were validated using enzymatic assays before pursuing efforts to improve the potency. Only when the C2 carboxylic acid was replaced with another ionizable functional group was reversible and competitive inhibition retained. Use of a tetrazole ring or 1,2,5-thiadiazolidine-3-one-1,1-dioxide as a carboxylate mimetic led to the discovery of two unique starting series that showed improved permeability (PAMPA) and potency of the order of 300 nM. The SAR from these efforts underscores some of the major challenges in developing small molecule inhibitors for PTP1B. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.02.043
  • 作为产物:
    描述:
    4-氧代哌啶酮盐酸盐苄磺酰氯potassium carbonate 作用下, 以 氯仿 为溶剂, 以95%的产率得到1-(benzylsulfonyl)piperidin-4-one
    参考文献:
    名称:
    N-磺酰基哌啶二螺-1,2,4,5-四恶烷在感染伯氏疟原虫 ANKA 的小鼠中表现出有效的体外抗疟原虫活性和体内功效
    摘要:
    青蒿素耐药性最近对消除疟疾构成了严重威胁。过去几年已经看到了几种基于过氧化物的药用化合物及其衍生物(例如三氧杂环己烷和四氧杂环己烷)的重要发展。在这里,我们报告了一种快速的一锅法合成一系列新的N-磺酰基哌啶二螺-1,2,4,5-四恶烷类似物,在四恶烷环上具有不同的取代,即各种取代的烷基和芳基磺酰氯,如以及环状、非环状和芳基取代的酮。所有合成的四恶烷均通过光谱(1 H NMR, 13C NMR)和光谱(高分辨率质谱)技术,并通过高效液相色谱(HPLC)分析进行量化。化合物19的结构经单晶XRD确证。从总体初步体外数据来看,类似物 14、16、19、20、24、41和44对恶性疟原虫( Pf 3D7) 菌株的潜在 IC 50值在纳摩尔范围内,介于 4.7 ± 0.3 至 12.9 ± 1.1 nM 之间人类疟疾寄生虫。此外,这些选择性类似物在体内评估了它们对伯氏疟原虫的抗疟潜力,结果显示类似物
    DOI:
    10.1016/j.ejmech.2022.114774
点击查看最新优质反应信息

文献信息

  • Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors:  From the Active Site to the Second Phosphotyrosine Binding Site
    作者:Douglas P. Wilson、Zhao-Kui Wan、Wei-Xin Xu、Steven J. Kirincich、Bruce C. Follows、Diane Joseph-McCarthy、Kenneth Foreman、Alessandro Moretto、Junjun Wu、Min Zhu、Eva Binnun、Yan-Ling Zhang、May Tam、David V. Erbe、James Tobin、Xin Xu、Louis Leung、Adam Shilling、Steve Y. Tam、Tarek S. Mansour、Jinbo Lee
    DOI:10.1021/jm0702478
    日期:2007.9.1
    Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of the insulin and leptin receptor pathways and thus an attractive therapeutic target for diabetes and obesity. Starting with a high micromolar lead compound, structure-based optimization of novel PTP1B inhibitors by extension of the molecule from the enzyme active site into the second phosphotyrosine binding site is described. Medicinal
    蛋白酪氨酸磷酸酶1B(PTP1B)是胰岛素和瘦素受体途径的负调节剂,因此是糖尿病和肥胖症的有吸引力的治疗靶标。从高微摩尔的先导化合物开始,描述了通过将分子从酶活性位点延伸到第二个磷酸酪氨酸结合位点来对新型PTP1B抑制剂进行基于结构的优化。在X射线复合物结构和分子建模的指导下,药物化学已经以有效的方式产生了低纳摩尔PTP1B抑制剂。发现来自该化学系列的化合物被主动转运到肝细胞中。这种对靶组织的主动摄取可能是克服PTP1B抑制剂膜通透性差的可能途径之一。
  • Inhibitors of protein tyrosine phosphatase 1B
    申请人:Lee Jinbo
    公开号:US20050203087A1
    公开(公告)日:2005-09-15
    Protein tyrosine phosphatases (PTPases) such as PTP1B can play a role in regulating a wide variety of cellular responses such as insulin signaling. Substituted thiophene compounds such as, for example, 2-carboxyl, 3-carboxymethoxy, 5-aryl substituted thiophenes, can inhibit PTP1B and thereby induce greater insulin sensitivity. Accordingly, PTP1B inhibition can provide an alternate treatment for PTPase-mediated disorders such as diabetes.
    蛋白酪氨酸磷酸酶(PTPases)如PTP1B可以在调节多种细胞反应中发挥作用,例如胰岛素信号传导。取代噻吩化合物,例如2-羧基、3-羧甲氧基、5-芳基取代的噻吩,可以抑制PTP1B,从而增加胰岛素敏感性。因此,PTP1B抑制可以作为PTPase介导的疾病(如糖尿病)的替代治疗方法。
  • PTP1B inhibitors
    申请人:Lee Jinbo
    公开号:US20080004325A1
    公开(公告)日:2008-01-03
    This invention relates to modulating (e.g., inhibiting) protein tyrosine phosphatase 1b (PTP1b).
    这项发明涉及调节(例如,抑制)蛋白酪氨酸磷酸酶1b(PTP1b)。
  • Lewis Acid-Directed Cyclocondensation of Piperidone Enol Ethers with 2-Methoxy-4-(<i>N</i>-phenylsulfonyl)-1,4-benzoquinoneimine:  A New Regioselective Synthesis of Oxygenated Carbolines
    作者:Thomas A. Engler、Jutta Wanner
    DOI:10.1021/jo9916176
    日期:2000.4.1
    Lewis acid-directed cyclocondensations of piperidone enol ethers with 2-methoxy-4-(N-phenylsulfonyl)-1,4-benzoquinoneimine are reported. Benzofurans are obtained with BF3. OEt2 as a promoter, whereas use of excess amounts of TiCl4:Ti(OiPr)(4) leads to tetrahydrocarbolines. The latter reactions provide expedient routes to oxygen-substituted tetrahydrocarbolines and carbolines. As applications of this new methodology, the preparations of 1-[3-(dimethylamino)propyl] amino-7-methoxy- and 1-[3-(dimethylamino)propyl]amino-7,8-dimethoxy-5H-pyrido[4,3-b]indoles are described.
  • US7521473B2
    申请人:——
    公开号:US7521473B2
    公开(公告)日:2009-04-21
查看更多